DOXORUBICIN INDUCED CARDIOMYOPATHY
Clinical trials for DOXORUBICIN INDUCED CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new DOXORUBICIN INDUCED CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for DOXORUBICIN INDUCED CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart shield? statin may guard against chemo damage
Disease control CompletedThis study tested whether atorvastatin, a cholesterol-lowering drug, can protect the heart in breast cancer patients receiving doxorubicin-based chemotherapy. 44 women with newly diagnosed breast cancer took atorvastatin daily for 3 months alongside their chemo. Researchers measu…
Matched conditions: DOXORUBICIN INDUCED CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Damanhour University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New scan spots chemo damage to heart and muscles early
Knowledge-focused CompletedThis study tested whether a special MRI scan (31P-MRS) can detect early signs of damage to heart and muscle cells caused by chemotherapy drugs like doxorubicin. Twelve cancer patients scheduled for chemo underwent three scans over time. The goal was to see if the scan could measu…
Matched conditions: DOXORUBICIN INDUCED CARDIOMYOPATHY
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC